Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

NCT03759340 is registered in ClinicalTrials.gov with Aclaris Therapeutics, Inc. as lead sponsor.

NCT NCT03759340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03759340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
Lead sponsor
Aclaris Therapeutics, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
January 15, 2019
Completion date
September 11, 2019
Enrollment
56 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata, alopecia totalis, alopecia universalis